MedVital Raises Rs 18 Crore in Growth Funding Round Led by Alkemi Growth Capital

Medtech startup MedVital has raised Rs 18 crore (approximately $2.1 million) in a growth funding round led by Alkemi Growth Capital, with participation from Shubhan Ventures, Sanjay Arora, and existing investors.

The company had previously secured backing from 4point0 Health Ventures along with several angel investors.

The fresh capital will be used to scale operations, accelerate product innovation, and strengthen capabilities across medical devices, biomaterials, and biologics.

Founded in 2024 by Dr. Varun Gupta and Tarun Bansal, MedVital develops healthcare technologies focused on advanced wound care, regenerative aesthetics, and chronic skin condition management.

The startup currently operates in the wound care segment through its NoWound portfolio, which includes negative pressure wound therapy systems and liquid bandage solutions designed for hospital and clinical use.

According to the company, its products have been adopted by more than 200 healthcare institutions across India, with growing repeat demand from hospitals and care providers.

MedVital has also expanded into regenerative aesthetics through its Elyara range, which focuses on non-invasive skin and hair restoration solutions.

The company is building an integrated medtech platform aimed at improving accessibility to advanced treatment solutions in India, particularly across wound management and regenerative care. 

As healthcare providers increasingly adopt technology-led wound care and aesthetic therapies, MedVital is positioning itself in the growing intersection of medical devices, biomaterials, and regenerative healthcare.

The Indian medtech/healthtech sector has been witnessing rising investor interest, particularly in specialised healthcare devices, chronic care management, and regenerative treatment technologies, as demand for advanced and accessible healthcare solutions continues to grow.